Sydney M Crago

Virtual Vision Health and VirtuaLens partner to enhance VR eye care tools, improving patient education and access to advanced diagnostic solutions.

Klinge Biopharma partners with Horus Pharma to commercialize the Eylea biosimilar FYB203 in Europe, enhancing market reach and therapeutic options.

A new staging system for diabetic retinopathy and macular edema is essential, integrating advanced imaging techniques for better disease management and patient outcomes.

EYP-1901 shows promising results in reducing treatment burden and improving vision in neovascular age-related macular degeneration, as revealed at EURETINA 2025.

The future of diabetic retinal imaging will be impacted by the use of widefield OCT-A technology, enhancing diagnosis and monitoring while addressing current limitations.

Lions World Vision Institute enhances corneal surgery with asymmetrical laser-cut CAIRS, offering tailored solutions for advanced keratoconus treatment.

Timothy Lai, MD, shares promising one-year results from the SALWEEN study on faricimab for polypoidal choroidal vasculopathy at EURETINA 2025.

OCT-A angiography can help reveal early neurodegenerative disease signs, offering a non-invasive method for identifying high-risk patients through retinal analysis.

OpZira Inc. launches innovative ophthalmic diagnostic tools, enhancing early detection and monitoring of ocular diseases for improved patient outcomes.

VirtuaLens revolutionizes cataract care with its VR IOL Simulator, empowering patients to make informed lens choices through immersive experiences.

Identifeye HEALTh is taking on retinal imaging, enhancing accessibility and integrating AI to improve patient care and streamline healthcare workflows.

Neurotech Pharmaceuticals enhances its leadership by appointing Peter J. McDonnell, MD, a leading ophthalmology expert, to its Board of Directors.

MCO-010 receives Orphan and RMAT designations, highlighting its potential as a groundbreaking therapy for various retinal dystrophies.

Jeremiah Tao, MD, FACS, highlights essential safety strategies in oculofacial surgery, emphasizing cost-effective techniques to prevent complications and enhance patient care.

AI enhances home OCT imaging to track wet AMD disease activity, enabling personalized patient management and improved treatment response monitoring.

Discover how dropless vitrectomy with suprachoroidal injection effectively controls inflammation, offering a promising alternative to traditional eye drop therapy.